Mind the gap: Estimating the opportunity lost due to the gap between FDA and EMA cancer drug approvals. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results